Vir Biotechnology, Inc. Finance Lease, Liability, Current
Vir Biotechnology, Inc. (VIR) had Finance Lease, Liability, Current of $265.00 thousand as of 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2021-02-25
- 2020-12-31: Finance Lease, Liability, Current $265.00K.
- 2020-09-30: Finance Lease, Liability, Current $253.00K.
- 2020-06-30: Finance Lease, Liability, Current $244.00K.
- 2020-03-31: Finance Lease, Liability, Current $240.00K.
| Period end | Finance Lease, Liability, Current |
|---|---|
| 2020-12-31 | $265.00K 10-K · filed 2021-02-25 |
| 2020-09-30 | $253.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $244.00K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $240.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $237.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $200.00K 10-Q · filed 2019-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |